Benign prostatic hyperplasia (BPH) is a benign enlargement of the prostate in which
incidence increases linearly with age, beginning at about 50 years old. BPH is a significant …

Background: With the progress of surgical techniques and instruments, various minimally
invasive surgical therapies were developed to treat benign prostatic hyperplasisa (BPH) …

Research has been consistently showing the role of zinc (Zn) in prostate function. In this
article, we review the current literature on the anatomy and main functions of the prostate …

Purpose Aim of this study was to evaluate a fully automated deep learning network named
Efficient Neural Network (ENet) for segmentation of prostate gland with median lobe …

Benign prostatic hyperplasia (BPH) is an age-related disease of the urinary system that
affects elderly men. Current treatments for BPH are associated with several adverse effects …

Purpose To summarize current evidence on outcomes and complications of prostatic artery
embolization as a treatment for patients with lower urinary tract symptoms secondary to …

Purpose The aim of this study was to investigate whether prostatic artery embolization (PAE)
can be considered a long-term cost-effective treatment option in patients with lower urinary …

Benign prostatic hyperplasia (BPH) is an age-related chronic disorder, characterized by the
hyperproliferation of prostatic epithelial and stromal cells, which drives prostate …

Background Evidence on clinical presentation of benign prostatic hyperplasia (BPH) is
scarce, and studies involving outpatients are lacking. We aimed to provide an insight into the …

Protocatechuic acid (PA) is a polyphenol—recognized for its efficacy as an antioxidant—
possesses anticancer, anti‐inflammatory, antioxidant properties. The efficacy of PA in the …